Cargando…
Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma
BACKGROUND: The primary goal of papillary thyroid cancer (PTC) management was to stratify patients at pre- and post-surgical level to identify the small proportion of cases with potentially aggressive disease. PURPOSE: The aim of our study is to evaluate the possible role of programmed cell death 4...
Autores principales: | Galuppini, Francesca, Fassan, Matteo, Bertazza, Loris, Barollo, Susi, Cascione, Luciano, Watutantrige-Fernando, Sara, Lazzarin, Vanni, Simonato, Paolo, Vianello, Federica, Rugge, Massimo, Mian, Caterina, Pennelli, Gianmaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708393/ https://www.ncbi.nlm.nih.gov/pubmed/31692513 http://dx.doi.org/10.2147/CMAR.S194344 |
Ejemplares similares
-
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling
por: Galuppini, Francesca, et al.
Publicado: (2022) -
Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario
por: Galuppini, Francesca, et al.
Publicado: (2019) -
Prognostic significance of the sum of the diameters of single foci in multifocal papillary thyroid cancer: the concept of new-old tumor burden
por: Manso, Jacopo, et al.
Publicado: (2020) -
Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients
por: Pezzani, Raffaele, et al.
Publicado: (2019) -
Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma
por: Cavedon, Elisabetta, et al.
Publicado: (2017)